PANACEABIO — Panacea Biotec Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹22.52bn
- IN₹21.42bn
- IN₹5.59bn
- 52
- 15
- 34
- 21
Annual cashflow statement for Panacea Biotec, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | C2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,442 | 14,488 | 128 | 14.8 | -79.5 |
| Depreciation | |||||
| Non-Cash Items | 1,839 | -14,987 | -1,350 | -424 | -447 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 209 | -1,022 | -3,394 | 77.3 | -95.5 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,067 | -1,084 | -4,225 | 34.7 | -274 |
| Capital Expenditures | -218 | -125 | -409 | -829 | -503 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -259 | 12,951 | 4,713 | 895 | 1,153 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -477 | 12,826 | 4,303 | 66.6 | 650 |
| Financing Cash Flow Items | -994 | -3,898 | -36 | -25.7 | -26.6 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -471 | -11,759 | -184 | -28.1 | -26.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 119 | -17.3 | -105 | 73.2 | 350 |